DE60319241D1 - Analoga zur behandlung von thalassämie - Google Patents

Analoga zur behandlung von thalassämie

Info

Publication number
DE60319241D1
DE60319241D1 DE60319241T DE60319241T DE60319241D1 DE 60319241 D1 DE60319241 D1 DE 60319241D1 DE 60319241 T DE60319241 T DE 60319241T DE 60319241 T DE60319241 T DE 60319241T DE 60319241 D1 DE60319241 D1 DE 60319241D1
Authority
DE
Germany
Prior art keywords
analogue
treatment
thalassemia
structural
angelicin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60319241T
Other languages
English (en)
Inventor
Nicoletta Bianchi
Monica Borgatti
Roberto Gambari
Ilaria Lampronti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universita degli Studi di Ferrara
Associazione Veneta per la Lotta alla Talassemia (AVLT)
Original Assignee
Universita degli Studi di Ferrara
Associazione Veneta per la Lotta alla Talassemia (AVLT)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universita degli Studi di Ferrara, Associazione Veneta per la Lotta alla Talassemia (AVLT) filed Critical Universita degli Studi di Ferrara
Application granted granted Critical
Publication of DE60319241D1 publication Critical patent/DE60319241D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Seasonings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Extrusion Moulding Of Plastics Or The Like (AREA)
DE60319241T 2002-07-31 2003-07-30 Analoga zur behandlung von thalassämie Expired - Lifetime DE60319241D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000684A ITTO20020684A1 (it) 2002-07-31 2002-07-31 Nuovo uso dell'angelicina e di suoi analoghi strutturali.
PCT/IB2003/003462 WO2004012729A1 (en) 2002-07-31 2003-07-30 Use of angelicin and of its structural analogues for the treatment of thalassemia

Publications (1)

Publication Number Publication Date
DE60319241D1 true DE60319241D1 (de) 2008-04-03

Family

ID=11459550

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60319241T Expired - Lifetime DE60319241D1 (de) 2002-07-31 2003-07-30 Analoga zur behandlung von thalassämie

Country Status (7)

Country Link
US (1) US7572827B2 (de)
EP (1) EP1545506B1 (de)
AT (1) ATE386513T1 (de)
AU (1) AU2003249472A1 (de)
DE (1) DE60319241D1 (de)
IT (1) ITTO20020684A1 (de)
WO (1) WO2004012729A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITVE20070005A1 (it) * 2007-01-25 2008-07-26 Associazione Veneta Per La Lotta Alla Talassemia Farmaco per la cura della talassemia, dell'anemia falciforme e di tutte le altre forme di anemia trattabili con questo, metodo di attivazione del farmaco, composizione farmaceutica avente come principio attivo il farmaco e metodo fotochemioterapico u
US7914821B2 (en) * 2008-03-07 2011-03-29 KO DA Pharmaceuticals Co., Ltd. Pharmaceutical composition for prevention and/or treatment of bone loss
GB0911215D0 (en) 2009-06-29 2009-08-12 Univ Erasmus Medical Ct Gamma globin therapy
GB201012420D0 (en) 2010-07-23 2010-09-08 Univ Erasmus Medical Ct Foetal heamoglobin inhibitor
ITMI20111068A1 (it) * 2011-06-14 2012-12-15 Azienda Ospedaliera Universitaria I Ntegrata Di Ve Trimetilangelicina come correttore di cftr in cellule dell'epitelio bronchiale
CN103626785A (zh) * 2013-11-05 2014-03-12 黄河科技学院 一种抗凝血补骨脂有效成分及其提取分离方法、应用
CN106399478A (zh) 2016-08-31 2017-02-15 桂林优利特医疗电子有限公司 一种荧光探针PCR 法快速检测α/β‑地中海贫血的试剂盒

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4021559A (en) 1974-12-30 1977-05-03 Synthelabo Method for treating sickle-cell anemia
US5569675A (en) * 1994-03-07 1996-10-29 Bar Ilan University Methods of using carboxylic acid esters to increase fetal-hemoglobin levels
JP3850468B2 (ja) * 1994-12-28 2006-11-29 中外製薬株式会社 エリスロポエチンのリポソーム製剤
FI100454B (fi) 1995-01-30 1997-12-15 Leiras Oy Hemi-tuotteiden uusi lääkinnällinen käyttö
WO1996040271A1 (en) * 1995-06-07 1996-12-19 Yale University Treatment of hemoglobinopathies

Also Published As

Publication number Publication date
ITTO20020684A0 (it) 2002-07-31
ITTO20020684A1 (it) 2004-02-01
AU2003249472A8 (en) 2004-02-23
EP1545506B1 (de) 2008-02-20
US7572827B2 (en) 2009-08-11
AU2003249472A1 (en) 2004-02-23
WO2004012729A1 (en) 2004-02-12
US20060111433A1 (en) 2006-05-25
ATE386513T1 (de) 2008-03-15
EP1545506A1 (de) 2005-06-29

Similar Documents

Publication Publication Date Title
HUP0202570A1 (hu) Izoflavonokat és analogonjait tartalmazó készítmények és terápiás alkalmazásuk
WO2005107872A3 (en) Treating respiratory diseases with gycopyrrolate and analogues
ATE390407T1 (de) Phenethanolamin-derivate zur behandlung von atemwegserkrankungen
ATE444296T1 (de) Analoga und prodrugs von buprenorphin
HK1070305A1 (en) Pharmaceutical composition comprising gabapentin or an analogue thereof and an sg(a)-aminoamide and its analgesic use
ATE396697T1 (de) Zuckerlacton enthaltende zusammensetzung zur haarbehandlung
DK1296671T3 (da) Gabapentinanaloger til sövnforstyrrelser
ATE486634T1 (de) Caspase 3, 8, 9 oder 10 inhibitoren in kombination mit mek inhibitoren zur behandlung von influenza
DE60319241D1 (de) Analoga zur behandlung von thalassämie
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
EP1422240A3 (de) Analoge des Nociceptins
DE50212646D1 (de) Verwendung von selenithältigen verbindungen zur topischen oder bukkalen anwendung
ATE319473T1 (de) Melagatran zur behandlung von entzündungen
DE602004031631D1 (de) Verwendung von betain zur behandlung von claudicatio intermittens
ATE406171T1 (de) Aplidine zur behandlung von multiplem myelom
DE60328022D1 (de) Neue verwendung von rapamycin und strukturellen analoga hiervon
DE602004029993D1 (de) Pharmazeutische zusammensetzung zur behandlung von drogenabhängigkeit
ATE449607T1 (de) Arsentherapie zur behandlung von autoimmunerkrankungen
DE60315666D1 (de) Furopyridin- und furopyrimidinderivate zur behandlung von hyperproliferativen erkrankungen
DE60305018D1 (de) Citalopram zur behandlung von bluthochdruck
WO2003097690A3 (en) Pth derivatives resistant to skin proteases
DE602005012317D1 (de) Verwendung von acetyl-l-carinitin zur behandlung des fibromyalgischen syndroms
DE60112802D1 (de) Verwendung von isovaleryl-l-carnitin zur herstellung eines arzneimittels zur vorbeugung und therapie von osteoporose
HUP0001414A2 (hu) Új paroxetinsó és azt tartalmazó gyógyászati készítmény
FR2812549B1 (fr) Associations dalfopristine/quinupristine avec le cefpirome

Legal Events

Date Code Title Description
8332 No legal effect for de